genzyme

Morning Market Snapshot: April 4, 2011

analysis, bp, business, financial, ford, genzyme, market, medtronic, morning, news, sanofi-aventis, southwest airlines, stock, trading, vivendi, vodafone

Good Morning. It's Monday, April 4, 2011. At this hour, U.S. equity futures are higher. Overseas, the Asian markets increased, while the European markets are mixed. Vivendi (VIVEF) and Vodafone (VOD) announced the signing of

By FNNO Staff
fnnonline@gmail.com

BlackRock Will Replace Genzyme Corp In S&P500 On April 1

Published on Wed, 03/30/2011 - 11:37
By FNNO Staff in General Interest, analysis, blackrock, blk, business, financial, genz, genzyme, market, news, s&p 500, standard & poor's, stock, trading, News Update

BlackRock has a potential upside of 14.4% based on a current price of $195.57 and an average consensus analyst price target of $223.82.

BlackRock is currently below its 50-day moving average (MA) of $195.69 and should find support at its 200-day MA of $172.97.

analysis, blackrock, blk, business, financial, genz, genzyme, market, news, s&p 500, standard & poor's, stock, trading

BlackRock (NYSE:BLK) will replace Genzyme Corp. (NASDAQ:GENZ) in the Standard & Poor's 500 Index after the close of trading on April 1, according to a Bloomberg report, which cited S&P.

By FNNO Staff
fnnonline@gmail.com

Genzyme Up 0.2% as Board Recommends Sanofi-Aventis Deal

Also today, Genzyme's board unanimously recommended that shareholders accept the deal with Sanofi for all shares of Genzyme common stock at $74 a share.

Genzyme shares are up 0.17%, or $0.13, to $75.78.

acquisition, business, financial news, genzyme, investing, market analysis, merger, sale, sanofi-aventis, shareholders, stock, trading

Shares of Genzyme (GENZ) are higher after Bloomberg reported that Chief Executive Henri Termeer will get $158.4 million in the sale of Genzyme to French drug maker Sanofi-Aventis (SNY).

By Stephanie Shyu
sshyu@fnno.com

Morning Market Snapshot: March 7th, 2011

analysis, business, financial, genzyme, james river coal company, market, news, pearson, posco, saint joe company, sanofi-aventis, stock, trading

Good Morning. It's Monday, March 7, 2011. At this hour, U.S. equity futures are higher. Overseas, the Asian markets gained, while the European markets are up. Sanofi-aventis (SNY) extends offer for Genzyme (GENZ) to April 1...

By FNNO Staff
fnnonline@gmail.com

Healthcare Sector Update: February 16, 2011

analysis, business, financial, genz, genzyme, healthcare, market, news, sanofi-aventis, sny, stock, trading

Health care shares are higher while Sanofi-Aventis (SNY) and Genzyme (GENZ) finally tie the knot for $20.1 billion, or $74 a share, in cash plus a contingent value right. Meanwhile, shares of Johnson & Johnson (JNJ) are down a

By FNNO Staff
fnnonline@gmail.com

What To Watch: February 16th 2011

abercrombie & fitch, anf, business, cablevision systems, cbs, clf, cliffs natural resources, comcast corp. cmcsa, comtex, cvc, de, dean food, deere, devon energy, df, dvn, express scripts, genz, genzyme, income, investment, market, news, nvda, nvidia, oc, owens corning, shares, sketchers, smartrend, stocks, trade, update

A full day of earnings today - Dean Foods (DF), Devon Energy (DVN), Owens Corning (OC), and Cablevision Systems (CVC) will report early on Wednesday, February 16th. Also reporting in the AM are Genzyme (GENZ), Deere (DE), Comcast

By Stephanie Shyu
sshyu@fnno.com

Sanofi-Aventis Agrees to Acquire Genzyme for $74 per Share

Sanofi-Aventis, Genzyme, GENZ, SNY, Merger, Acquisition, Stock, Trading, Market, Analysis, Financial, News, Business,

Sanofi-Aventis (NYSE: SNY) announced that it reached an agreement with Genzyme Corporation (NASDAQ:GENZ) where it will acquire Genzyme for $74 per share.

By FNNO Staff
fnnonline@gmail.com

What's In The News: February 14th, 2011

aig, analysis, apple, business, discovery communications, earnings, eps, finance, genzyme, news, research in motion, sanofi-aventis, stock, trading, whats in the news

The Financial Times reports that The U.S. is looking to woo sovereign wealth funds to buy a big piece of the authorities' sale of up to $20B worth of shares in AIG (AIG), ...the Wall Street Journal reports that Research in Motion

By Peter Chu
pchu@fnno.com

The Week Ahead: February 14, 2011

Monday, February 14th kicks off earnings reports from MGM Resorts (MGM) before the opening bell and Agilent Technologies (A), Marriott (MAR), and FMC Technologies (FTI) after market close. No major economic reports are scheduled f

On Tuesday, February 15th, you can expect Sirius XM Radio's (SIRI) earnings report early on the morning. Rovi Corp (ROVI), Tesla Motors (TSLA), Allscripts Healthcare (MDRX), and Dell (DELL) will be reporting their earnings in the

a, abercrombie, agilent tech, allscripts, anf, apa, apache, bell, brcd, brocade, building, business, cablevision, campbell soup, cbs, cf industries, clearwire, clf, cliffs, clwr, cmcsa, comcast, computer, consumer, cpb, cvc, data, de, dean, deere, dell, devon, df, dps, dr pepper, earnings, economic report, energy, eog, esrx, express, fed, financial, first solar, fmc, foods, fslr, fti, genz, genzyme, healthcare, housing, hun, huntsman, import, industrial, jm smucker, jobless, jwn, liz caliborne, manufacturing, market, marriott, mdrx, mgm, motors, newfield exploration, nfx, nordstrom, nvda, nvidia, oc, owens corning, price, producer, resources, retail, rovi, sales, shoes, siri, siriux, sjm, skechers, skx, snapple, stock market, tesla, TSLA, tv, unemployment, waste management, wm, xm radio

Here's a look at earnings and economic data for the week of February 14th.

By FNNO Staff
fnnonline@gmail.com

Sanofi-Aventis May Extend Genzyme Offer a Third Time

Sanofi CEO Chris Viehbacher reportedly told the paper that "it's a possibility" and noted that there is no time limit in the US on takeover bids.

Sanofi ADRs are down 1.1%, or $0.38, to $34.31. Genzyme shares are down 0.1%.

sanofi aventis, sny, genzyme, genz, bid, takeover, offer, merger, acquisition, chris viehbacher, adrs, shares, stock market, financial

Sanofi-Aventis (SNY) may extend its offer for Genzyme (GENZ) for a third time, Bloomberg reported, citing the French daily newspaper La Tribune.

By Stephanie Shyu
sshyu@fnno.com

Latest News from FNNO

Earnings Look Back: Comcast Is Up 3.1% S...

When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...

Earnings Look Back: Kelly Services Is Up...

When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...

Liberty Media Earnings Review: 10 Days a...

When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...

Central Garden and Pet Earnings Hindsigh...

A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...

Comcast Earnings Review: 17 Days after A...

When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...

Jazz Pharmaceuticals Earnings In Retrosp...

11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...

Most Popular Video News